← All trials
NCT07221149
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 9, 2026
- Primary completion
- Nov 8, 2030
- Completion date
- Sep 11, 2032
- First posted
- Oct 27, 2025
- Last posted
- Nov 25, 2025
- Enrollment
- 690
- Arms / groups
- 5 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Bristol-Myers SquibbLead sponsor
- Bristol-Myers SquibbOfficial
- BiontechCollaborator
Drugs studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.